Radiofrequency ablation versus hybrid argon plasma coagulation in Barrett's esophagus: a prospective randomised trial.

"Declarations DisclosureMate Knabe, Johannes Richl, Sandra Blößer, and Andrea May received funds for another study by Erbe Elektromedizin Tübingen, Germany. The present trial was investor initiated and was not funded by any company. Mate Knabe, Jens Wetzka, Lukas Welsch, Johannes Richl, Florian Michael, Sandra Blößer, Myriam Heilani, Holger Kronsbein, Andrea May have no conflicts of interest or financial ties to disclose. Ethical approvalThe study protocol was approved by the General Medical Council of the state of Hesse (FF100/2017) and registered in the German trial registry (DRKS-ID: DRKS00013026). Disclosure Mate Knabe, Johannes Richl, Sandra Blößer, and Andrea May received funds for another study by Erbe Elektromedizin Tübingen, Germany. The present trial was investor initiated and was not funded by any company. Mate Knabe, Jens Wetzka, Lukas Welsch, Johannes Richl, Florian Michael, Sandra Blößer, Myriam Heilani, Holger Kronsbein, Andrea May have no conflicts of interest or financial ties to disclose."

"Funding Open Access funding enabled and organized by Projekt DEAL."

"The study is a randomized trial and was conducted prospectively in a tertiary care centre in Germany (12/2017–05/2022). All of the endoscopists involved had sufficient experience in interventional Barrett’s esophagus therapy (each having treated over 100 patients with neoplastic Barrett’s esophagus). The study protocol was approved by the General Medical Council of the state of Hesse (FF100/2017) and registered in the German trial registry (DRKS-ID: DRKS00013026). Declarations: DisclosureMate Knabe, Johannes Richl, Sandra Blößer, and Andrea May received funds for another study by Erbe Elektromedizin Tübingen, Germany. The present trial was investor initiated and was not funded by any company. Mate Knabe, Jens Wetzka, Lukas Welsch, Johannes Richl, Florian Michael, Sandra Blößer, Myriam Heilani, Holger Kronsbein, Andrea May have no conflicts of interest or financial ties to disclose.: Ethical approvalThe study protocol was approved by the General Medical Council of the state of Hesse (FF100/2017) and registered in the German trial registry (DRKS-ID: DRKS00013026). Ethical approval: The study protocol was approved by the General Medical Council of the state of Hesse (FF100/2017) and registered in the German trial registry (DRKS-ID: DRKS00013026)."